文献速递前列腺癌

Node-RADS评分对接受根治性前列腺切除联合扩大淋巴结清扫的前列腺癌患者的预测作用:与经验证列线图的对比分析

Predictive role of node-rads score in patients with prostate cancer candidates for radical prostatectomy with extended lymph node dissection: comparative analysis with validated nomograms.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2022-06-22

回顾性分析150例接受根治性前列腺切除联合扩大盆腔淋巴结清扫的前列腺癌患者,评估术前磁共振Node-RADS评分预测盆腔淋巴结转移的价值,并与MSKCC、Briganti 2012、Gandaglia 2017及Gandaglia 2019列线图比较。Node-RADS 4-5分阳性预测值为100%,但灵敏度低(0.167),特异度高于各列线图,曲线下面积相似。

要点

  • Node-RADS 4-5分预测pN+的阳性预测值为100%,阴性预测值为79.6%。
  • Node-RADS 4-5分灵敏度0.167,低于各列线图的0.972、1.000、0.971、0.960。
  • Node-RADS 4-5分特异度1.000,高于各列线图的0.079、0.096、0.138、0.186。

核心结论

  • Node-RADS评分结合形态学标准与大小判定,可能提高预测病理性盆腔淋巴结转移的特异度,但灵敏度很低。

研究设计与样本

  • 回顾性分析2018年至2021年150例组织学诊断前列腺癌患者,接受根治性前列腺切除联合扩大盆腔淋巴结清扫。
  • 纳入标准为高危或中危且Briganti列线图估计pN+风险高于5%或Gandaglia列线图估计风险高于7%。
  • 所有病例术前磁共振由对病理结果盲法的放射科医生进行Node-RADS判定,并与MSKCC、Briganti 2012、Gandaglia 2017及Gandaglia 2019列线图比较。

主要发现

  • 最终病理盆腔淋巴结转移(pN+)36/150例(24.0%),pN+病例中阳性淋巴结平均百分比为15.90±13.40。
  • 根治性前列腺切除中切除的盆腔淋巴结平均数量在pN0组(23.9±8.0)与pN+组(25.3±8.0)之间相似(p=0.188)。
  • 以Node-RADS 4-5分为阳性、Node-RADS 1-2分为阴性,阳性预测值为100%,阴性预测值为79.6%。
  • Node-RADS 4-5分灵敏度0.167,低于MSKCC、Briganti 2012、Gandaglia 2017及Gandaglia 2019列线图的0.972、1.000、0.971、0.960。
  • Node-RADS 4-5分特异度1.000,高于上述列线图的0.079、0.096、0.138、0.186;曲线下面积0.583,与各列线图的0.591、0.581、0.574、0.597相似。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The Reporting and Data System (RADS) have been used in the attempts to standardize the results of oncological scans in different scenarios, such as lymph nodes, adding configuration criteria to size determination. We analyze the predictive value of preoperative Node-RADS determination at imaging for pelvic lymph node (PLN) involvement in cases of prostate cancer (PC) considered for radical prostatectomy (RP) with extended lymph node dissection (eLND) and we compare it with validate predictive nomograms (MSKCC, Briganti and Gandaglia). METHODS: 150 patients with a histological diagnosis of PC (high risk or intermediate with an estimated risk for pN+ higher than 5% using the Briganti or 7% using the Gandaglia nomogram) submitted for RP with an ePLND from 2018 and 2021 were retrospectively examined. Node-RADS determination was performed in all cases using the preoperative magnetic resonance (MR), performed by a radiologist blinded for pathologic results and compared with the MSKCC, Briganti 2012, Gandaglia 2017 and Gandaglia 2019 nomograms. RESULTS: PLN involvement at final pathology (pN+) was found in 36/150 (24.0%) of cases and the mean percentage of positive LNs in pN+ cases was 15.90 ± 13.40. The mean number of PLNs removed at RP was similar (p = 0.188) between pN0 (23.9 ± 8.0) and pN+ (25.3 ± 8.0) cases. Considering a Node RADS 4-5 positive and a Node RADS 1-2 negative, the PPV was 100% and the NPV was 79.6%. A Node RADS score 4-5 showed a lower sensitivity (0.167 versus 0.972, 1.000, 0.971, 0.960 respectively), a higher specificity (1.000 versus 0.079, 0.096, 0.138, 0.186 respectively) and a similar AUC (0.583 versus 0.591, 0.581, 0.574, 0.597 respectively) when compared to MSKCC, Briganti 2012, Gandaglia 2017 and Gandaglia 2019 nomograms. CONCLUSIONS: Our evaluation suggests that Node RADS score, combining configuration criteria to size determination could improve specificity in terms of pathologic PLN prediction but a very low sensitivity has been also described.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Lucciola S, Pisciotti ML, Frisenda M, et al. Predictive role of node-rads score in patients with prostate cancer candidates for radical prostatectomy with extended lymph node dissection: comparative analysis with validated nomograms. Prostate Cancer Prostatic Dis. 2022. PMID: 35732820. doi:10.1038/s41391-022-00564-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。